Kingwood, TX

Activian Clinical Research

Obesity

Disease

Overnutrition

Musculoskeletal Diseases

Arthritis

Human Influenza

Nutrition Disorders

Overweight

Type 2 Diabetes Mellitus

Cancer

LY3298176

LY3502970

Orforglipron

Tirzepatide

Bimagrumab

Lilly

Harbinger Health

Moderna

condition

Joint Diseases

Osteoarthritis

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 74 weeks.

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Activian Clinical Research | Kingwood, TX

Site insights

Work at this site?

Active trials

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee (ATTAIN-OA PAIN)

Trial sponsors